These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31265946)

  • 1. Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.
    Linafelter A; Cuna A; Liu C; Quigley A; Truog WE; Sampath V; Oschman A
    Early Hum Dev; 2019 Sep; 136():1-6. PubMed ID: 31265946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory effects of prolonged prednisolone use in infants with evolving and established Bronchopulmonary dysplasia.
    Liviskie C; Vesoulis Z; Zeller B; Rao R; McPherson C
    Early Hum Dev; 2021 May; 156():105344. PubMed ID: 33684601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia.
    Bhandari A; Schramm CM; Kimble C; Pappagallo M; Hussain N
    Pediatrics; 2008 Feb; 121(2):e344-9. PubMed ID: 18245407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants.
    Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE;
    JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm.
    Cuna A; Liu C; Govindarajan S; Queen M; Dai H; Truog WE
    J Pediatr; 2018 Jun; 197():23-28.e2. PubMed ID: 29551313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.
    Reiterer F; Scheuchenegger A; Resch B; Maurer-Fellbaum U; Avian A; Urlesberger B
    Pediatr Int; 2019 Apr; 61(4):381-387. PubMed ID: 30793436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
    Jensen EA; White AM; Liu P; Yee K; Waber B; Monk HM; Zhang H
    Am J Perinatol; 2016 Jan; 33(1):107-13. PubMed ID: 26295968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
    Nyp MF; Taylor JB; Norberg M; Truog WE
    Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation.
    Malikiwi AI; Lee YM; Davies-Tuck M; Wong FY
    Early Hum Dev; 2019 Apr; 131():29-35. PubMed ID: 30825742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia.
    Caskey S; Gough A; Rowan S; Gillespie S; Clarke J; Riley M; Megarry J; Nicholls P; Patterson C; Halliday HL; Shields MD; McGarvey L
    Ann Am Thorac Soc; 2016 Aug; 13(8):1262-70. PubMed ID: 27222921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 15. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
    BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous pulses of methylprednisolone for infants with severe bronchopulmonary dysplasia and respiratory support after 3 months of age.
    Billion E; Hadchouel A; Garcelon N; Delacourt C; Drummond D
    Pediatr Pulmonol; 2021 Jan; 56(1):74-82. PubMed ID: 33034950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronology and Determinants of Respiratory Function Changes Following Administration of Systemic Postnatal Corticosteroids in Extremely Preterm Infants.
    Dassios T; Kaltsogianni O; Hickey A; Bhat R; Greenough A
    J Pediatr; 2019 Dec; 215():17-23. PubMed ID: 31500862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing relationship between bronchopulmonary dysplasia and cognition in very preterm infants.
    Brumbaugh JE; Colaizy TT; Patel NM; Klein JM
    Acta Paediatr; 2018 Aug; 107(8):1339-1344. PubMed ID: 29333635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
    Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
    Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.